CD80 and neoplasm: In particular, CTLA-4/B7 blocking in murine models results in increased IL-2 and interferon-gamma (IFN-γ) production by lymphocytes, increased expression of major histocompatibility complex (MHC) class I molecules, and markedly increased tumor killing [22,23].